HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Canadian Authorities Say Some Cosmetic Talc Applications May Endanger Human Health

Executive Summary

Health Canada and Canada’s environmental agency issued a draft screening assessment Dec. 8 identifying talc as potentially hazardous to consumers when used in cosmetic powders that may be inhaled or products applied to female genitals. Finalization of the assessment in its current form would trigger risk management actions.

You may also be interested in...



J&J CEO Sees Victory Ahead On Talc, Growth From Johnson's Relaunch

JP Morgan analysts had questions and J&J CEO Alex Gorsky and CFO Joseph Wolk had answers about liability suits alleging that use of the Johnson's brand talcum powder has caused mesothelioma or ovarian cancer. On the Johnson's brand outlook following its relaunch as a natural product line, Gorsky says sales were a key driver in the firm's consumer health sales in the 2018 third quarter. China, meanwhile, is a model for growing sales online, he says.

J&J Doing Damage Control Following Reuters Report On Asbestos ‘Lurking’ In Johnson’s Powder

J&J shares are down nearly 12% since Reuters reported Dec. 14 that the firm has known for decades about toxic asbestos in its Johnson’s Baby Powder talc. The news outlet’s probe turned up nothing that hasn’t been raised by plaintiff attorneys, but throws the central issues of contention into high relief for its global audience.

J&J Doing Damage Control Following Reuters Report On Asbestos ‘Lurking’ In Johnson’s Powder

J&J shares are down nearly 12% since Reuters reported Dec. 14 that the firm has known for decades about toxic asbestos in its Johnson’s Baby Powder talc. The news outlet’s probe turned up nothing that hasn’t been raised by plaintiff attorneys, but throws the central issues of contention into high relief for its global audience.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS139940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel